Atila Biosystems

Mountain View, United States Founded: 2009 • Age: 17 yrs
Isothermal amplification-based molecular diagnostics are provided for HPV assays.
Request Access

About Atila Biosystems

Atila Biosystems is a company based in Mountain View (United States) founded in 2009.. Atila Biosystems offers products and services including Cancer Detection Assays, Blood Screening Assays, Respiratory Infection Assays, Bacterial Infections Assays, and NGS Library Preparation Assays. Atila Biosystems operates in a competitive market with competitors including Great Basin Scientific, Tangen Biosciences, HiberGene, RX Ventures and certus molecular diagnostics, among others.

  • Headquarter Mountain View, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $2 M (USD), Grant

    Sep 05, 2022

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Atila Biosystems

Atila Biosystems offers a comprehensive portfolio of products and services, including Cancer Detection Assays, Blood Screening Assays, Respiratory Infection Assays, Bacterial Infections Assays, and NGS Library Preparation Assays. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Assays for detecting cancer-related nucleic acids accurately

Tests for screening blood samples for various conditions

Assays to identify respiratory viruses and bacteria

Tests for detecting bacterial pathogens in samples

Assays for preparing libraries in next-generation sequencing

Tests to identify drug resistance in pathogens

Assays for detecting infections in wound samples

Tests for sexually transmitted infections and related conditions

Assays to identify infections in the urethral tract

Tests for detecting fungal pathogens

People of Atila Biosystems
Headcount 10-50
Employee Profiles 9
Employee Profiles
People
Xinhao Song
Research And Development Scientist
People
Bo Jiang
Scientist
People
Farzaneh Tondnevis
Senior Scientist
People
Yifan Chen
Software Engineer

Unlock access to complete

Funding Insights of Atila Biosystems

  • Total Funding
  • Total Rounds 1
  • Last Round Grant — $2.0M
  • First Round

    (05 Sep 2022)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Sep, 2022 Amount Grant - Atila Biosystems Valuation

investors

HHS
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Atila Biosystems

Atila Biosystems has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Atila Biosystems

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Atila Biosystems

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Atila Biosystems Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Atila Biosystems

Atila Biosystems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Great Basin Scientific, Tangen Biosciences, HiberGene, RX Ventures and certus molecular diagnostics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Chip-based molecular diagnostics for infectious diseases are commercialized.
domain founded_year HQ Location
Developer of a molecular diagnostics platform
domain founded_year HQ Location
Develops and manufactures diagnostic tests for infectious diseases like meningitis.
domain founded_year HQ Location
Develops innovative technologies for amplification-based diagnosis of chronic health conditions.
domain founded_year HQ Location
Rapid tests for detecting specific microorganism genes are provided.
domain founded_year HQ Location
Genetic testing systems for Covid-19 detection are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about Atila Biosystems

When was Atila Biosystems founded?

Atila Biosystems was founded in 2009 and raised its 1st funding round 13 years after it was founded.

Where is Atila Biosystems located?

Atila Biosystems is headquartered in Mountain View, United States. It is registered at Mountain View, California, United States.

Who is the current CEO of Atila Biosystems?

Youxiang Wang is the current CEO of Atila Biosystems.

What does Atila Biosystems do?

Atila Biosystems was founded in 2009 and is based in Mountain View, United States. Operations focus on the biotechnology sector, where proprietary isothermal amplification technology is commercialized through high-multiplex, probe-based real-time fluorescent assays targeted at HPV detection. Complex samples are accommodated by the technology, which employs a single-step pipetting protocol. Compatibility is ensured with major qPCR instruments for all diagnostic kits.

Who are the top competitors of Atila Biosystems?

Atila Biosystems's top competitors include Great Basin Scientific, Tangen Biosciences and certus molecular diagnostics.

What products or services does Atila Biosystems offer?

Atila Biosystems offers Cancer Detection Assays, Blood Screening Assays, Respiratory Infection Assays, Bacterial Infections Assays, and 6 more products and services.

Who are Atila Biosystems's investors?

Atila Biosystems has 1 investor. Key investors include HHS.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available